Received Jun 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 2 | PE9G5 | — |
Expire dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 57-year-old female patient who received HBV (Engerix B) (batch number PE9G5, expiry date 19-MAY-2025) for prophylaxis. Concomitant products included Hepatitis b vaccine rHBsAg (yeast) (Engerix b). On 16-JUN-2025, the patient received the 2nd dose of Engerix B. On 16-JUN-2025, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: Expire dose). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 17-JUN-2025 A patient was accidentally administered an expired dose of Engerix-B which led to expired vaccine use. So, the reporter contacted the CDC they said that they would have to repeat the dose. The reporter was trying to find out if there was a grey period between the expiration date and the date of administration, that it might still count. Also, this was the 2nd Engerix-B dose, the 1st was administered on 14th May 2025. The lot number that healthcare professional provided (PE9G5) was for the 2nd dose.
Engerix b